New innovative local treatment for osteolytic bone disease in multiple myeloma Date: January 14, 2025 Source: Vrije Universiteit Brussel Summary: A team of researchers has developed a new ...

The team tackled a critical challenge in treating multiple myeloma—a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients.

The team tackled a critical challenge in treating multiple myeloma-a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients.

“In the randomized, phase 3 AURIGA study, the addition of [Darzalex] to [Revlimid] maintenance resulted in a significantly higher MRD-negative conversion rate among transplant-eligible patients with ...

Healthy plasma cells make antibodies that are important for immunity. But with multiple myeloma, cancer cells crowd out the normal cells and create an abnormal antibody called M protein, high ...